Diabetes is associated with accelerated atherosclerosis, diffuse coronary artery disease (CAD), more extensive disease burden, increased mortality, and higher repeat revascularization after initial revascularization strategies [12] . The FREEDOM (Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease) trial compared percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) in 1900 diabetic patients with multivessel CAD but excluded left main (LM) disease [3] . PCI was associated with a higher mortality at 5 years follow up compared with CABG in patients with diabetes and multivessel CAD [3] . In the FREEDOM follow-up study, the all-cause mortality rate was significantly higher with PCI at 8 years [4] .